H istone H3 lysine 4 trimethylation (H3K4me 3 ) has been associated with transcriptionally active promoters (1, 2) . Mammals have at least 6 different H3K4-specific methyltransferases; in mice these are KMT2A (ALL1/CXXC7/MLL1), KMT2B (MLL2/ WBP7), KMT2C (MLL3), KMT2D (MLL4), KMT2E (SET1A), and KMT2F (SET1B). Murine Mll2 is a paralogue of Mll1 and is the orthologue of human MLL4. Mll2 resides on mouse chromosome 7 (mm9 chr7: 31353874 to 31369215) and codes for the KMT2B methlytransferase. These enzymes have at least some nonredundant functions, as depletion of either KMT2A or KMT2B is embryonically lethal (3) (4) (5) . KMT2A is the most studied of the H3K4 methyltransferases, as it is involved in various leukemogenic translocations (6, 7) . These aberrant fusion proteins function by recruiting a constitutively active, transcriptional elongation-promoting complex to promoters (8) (9) (10) .
In Saccharomyces cerevisiae, Set1 is the only enzyme responsible for H3K4me 3 deposition and is recruited to the initiating form of RNA polymerase II (Pol II) (11) , suggesting that the H3K4me 3 mark is deposited after transcription has initiated. In mice, depletion of KMT2A results in transcriptional silencing, abnormal RNA polymerase II distribution, loss of histone acetylation, and CpG island promoter methylation on a subset of the Hox genes (12) (13) (14) . These results suggest that KMT2A recruitment is crucial for the association of the basal transcription machinery and is involved in setting up a permissive chromatin landscape for transcription as well as preventing DNA methylation. However, direct evidence for this idea has so far been lacking.
In contrast to KMT2A, the KMT2B function is less characterized. In embryonic stem (ES) cells, only a small number of genes are significantly downregulated in response to KMT2B depletion, the most prominent of which is MagohB (15) . MagohB is regulated by a CpG island promoter, and it is expressed in all tissues examined so far, including ES cells (15) . MagohB expression is abso-lutely dependent on KMT2B in ES cells, with no apparent functional redundancy from other H3K4 methyltransferases. MagohB transcriptional silencing in the absence of KMT2B is characterized by loss of H3K4me 3 and increased DNA methylation over the MagohB CpG island promoter (15) . This phenomenon is similar to what has been observed on the Hox genes in cells lacking KMT2A (12) (13) (14) . However, the order of events leading to the establishment of the silenced state is unknown in either case. In addition, the interdependency between RNA polymerase II binding and MLL2 association is unclear. We used ES cells carrying a conditional allele of Mll2 to address these questions and performed kinetic experiments aimed at dissecting the molecular events leading to MagohB silencing and DNA methylation. Here we present direct evidence that the presence of KMT2B is required for the stable maintenance of the basal transcription machinery and for maintaining low levels of DNA methylation. Our experiments demonstrate that DNA methylation is a rapid process that is secondary to gene silencing. Moreover, we demonstrate that reexpression of MLL2 is sufficient to reactivate the methylated MagohB promoter.
MATERIALS AND METHODS
Cell lines and cell culture. Wild-type mouse ES cells (129P2 background; here termed E14) and Mll2 Ϫ/Ϫ , Mll2 F/F , and Mll2 F/ϩ ES cells (5, 15, 16) were provided by A. F. Stewart and were grown in high-glucose Dulbecco modified Eagle medium supplemented with 15% serum (PAA Gold fetal bovine serum), 1,000 U/ml leukemia inhibitory factor (ESGRO; Millipore), 25 mM HEPES, 1 mM sodium pyruvate, 2 mM L-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, 1ϫ nonessential amino acids (Sigma), and 0.15 mM monothioglycerol at 37°C in 5% CO 2 on tissue culture-grade plastics at a density of 10 4 cells/cm 2 . Cells were split every 2 to 3 days as necessary by brief trypsinization in an appropriate volume of 1ϫ trypsin-EDTA at room temperature.
Genotyping. The Mll2 F/F and Mll2 F/ϩ ES cells were tested for recombination of the Mll2 alleles twice by Southern blotting and after that by PCR and agarose gel electrophoresis every time that they were induced with 4-hydroxytamoxifen (OHT). OHT was added to the culture medium at a final concentration of 10 Ϫ7 M. The genotyping PCR was performed using primers 145se (CGGAGGAAGAGAGCAGTGACG) and 147as (GG ACAGGAGTCACATCTGCTAGG). The 145se/147as primer pair detects all Mll2 alleles.
Disruption of RNA polymerase II by ␣-amanitin and DRB. Cells were grown as described above. 5,6-Dichlorobenzimidazole-1-␤-D-ribofuranoside (DRB; Sigma) or ␣-amanitin (Sigma) was added to the culture medium to give a final concentration of 100 M or 5 g/ml, respectively. The cells were cultured for up to 24 h in DRB and up to 48 h in ␣-amanitin and then harvested using a method suited for the downstream analyses.
Transfections. pCAGGS-FlpO-IRES-puro transfections were performed in 6-well plates using Lipofectamine LTX with Plus reagent (Invitrogen) according to the manufacturer's instructions. The transfected cells were grown in puromycin-containing medium for 24 h, harvested as a bulk population, and expanded for the time periods indicated in the relevant figures. Cells were cotransfected with 100fold less of a green fluorescent protein (GFP)-expressing plasmid. Fluorescence-activated cell sorter analysis revealed that at least 95% of cells expressed GFP.
DNase I-hypersensitive site (DHS) mapping. The method employed for DNase I treatment is an adaptation of the method described by Pfeifer and Riggs (17) . Southern blot transfer and hybridization were performed as described by Cockerill (18) .
In vivo footprinting. Footprinting experiments were performed as described by Tagoh et al. (19) , using Phusion polymerase (New England Biolabs) and the GC-specific buffer instead of the suggested Pfu polymerase. Micrococcal nuclease (MNase) digestions were performed using the Measurement of DNA methylation. (i) Pyrosequencing. Genomic DNA was treated with sodium bisulfite using an EZ-DNA methylation kit from Zymo Research according to the manufacturer's instructions. Bisulfite-converted DNA was used as a PCR template to amplify the MagohB promoter using biotinylated primers specific for the converted DNA sequence (forward sequence, AGTAGAGAAGGTAGAAATTATTATTTA TAG; reverse sequence, [biotin]-CTCTTAAAAATCTCTTACTTCCTCT TC). PCR products were purified using streptavidin-coated magnetic beads and prepared for sequencing using a third sequencing primer (SEQ [GGTAGAAATTATTATTTATAGATAT]).
(ii) HpaII digestion. Five hundred micrograms of genomic DNA was digested to completion with HpaII. The digests were used as the template for quantitative PCRs (QPCRs) with primers flanking a single HpaII site on the MagohB promoter (MagohB HpaII forward primer, TTCTCTTG GGGGTCTCTTGCTTCC; MagohB HpaII reverse primer, CGCGTCAC CAAGGGCGCGTT). Data were subsequently normalized against a PCR amplicon on the Oct4 promoter that does not contain an HpaII site.
(iii) Methylated DNA immunoprecipitation (MeDIP) and hydroxymethylated DNA immunoprecipitation (HmeDIP). Five micrograms per immunoprecipitation (IP) of anti-methylated C (ab10805; Abcam) and anti-hydroxymethylated C (ab106918; Abcam) antibody each was incubated with 10 l protein G Dynabeads (10004D; Life Technologies) for 2 h at 4°C with rotation. One hundred microliters purified genomic DNA (2 g/IP) was added to the bead-antibody complexes, and the mixture was incubated overnight at 4°C with rotation. The beads were separated using a magnetic separator and washed once with each of the following: wash buffer 1 (20 mM Tris, pH 8.0, 2 mM EDTA, 1% Triton X-100, 0.1% SDS, 150 mM NaCl), wash buffer 2 (20 mM Tris, pH 8.0, 2 mM EDTA, 1% Triton X-100, 0.1% SDS, 500 mM NaCl), and TE-NaCl buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 50 mM NaCl). Finally, the immunoprecipitated DNA was eluted in 0.1 M NaHCO 3 , 1% SDS, 200 mM NaCl containing 200 g/ml proteinase K by a 4-h incubation at 65°C. The eluted DNA was purified using an Agencourt Ampure XP PCR cleanup kit and used as the template for a QPCR with primers specific for the MagohB promoter (forward primer, TACTCCGGTAGGAACGAAA; reverse primer, CTCCAATGCGAACCTTCAGT).
RNA and protein purification. Total RNA and protein were purified using an RNeasy kit (Qiagen) according to the manufacturer's instructions.
cDNA synthesis and QPCR. Moloney murine leukemia virus reverse transcriptase (Invitrogen) was used to reverse transcribe 1 g total RNA according to the manufacturer's instructions. QPCR was performed on an ABI 7900HT or ABI 7500 real-time PCR instrument using ABI SYBR green master mix. Initial data analysis (threshold/baseline) was performed by ABI SDS software, and further analyses were performed in the Microsoft Excel program. Standard curve quantitation was performed for all QPCR experiments. The primer sequences used in mRNA expression measurements were as follows: for Gapdh (glyceraldehyde-3-phosphate dehydrogenase gene), forward primer ACCTGCCAAGTATGATGAC ATCA and reverse primer GGTCCTCAGTGTAGCCCAAGAT; for Oct4, forward primer AGGTGGAACCAACTCCCGAG and reverse primer GC TTCAGCAGCTTGGCAAC; and for MagohB, forward primer CGGGCA TAAGGGCAAGTTT, primary RNA forward primer TGGGACTATGAA ATTGTCTTTACC, and reverse primer AATTACTGTTGTTGGCATAT GTAAGCTT.
ChIP. Chromatin immunoprecipitation (ChIP) assays were performed as described previously (20) with modifications. ES cells were fixed in situ by addition of formaldehyde (final concentration, 1%) in the culture medium and incubation for 12 min. Nuclei were prepared from the fixed cells, and the contained chromatin was sheared by sonication in a Diagenode Bioruptor (high setting, 8 cycles of 30 min of pulse and 30 min of pause at 4°C). Immunoprecipitation was performed using antibodies against the RNA Pol II carboxy-terminal domain (CTD) (ab5408; Abcam), H3K4me 3 (07-473; Millipore), and acetylated H3K9 (H3K9ac; ab4441; Abcam). The immunoprecipitated DNA was amplified by QPCR as described above. Primer sequences used in ChIP-QPCR were as follows: for the MagohB promoter, forward primer TACTCCGGTAGGAA CGAAA and reverse primer CTCCAATGCGAACCTTCAGT; for the Oct4 promoter, forward primer TGGGCTGAAATACTGGGTTC and reverse primer TTGAATGTTCGTGTGCCAAT.
SDS-PAGE and Western blotting. Whole-cell extracts from equal amounts of cells were separated on a Bio-Rad 4 to 20% gradient mini-Protean TGX precast gel. Proteins were transferred onto a nitrocellulose membrane by wet transfer. Membranes were blocked with 5% (wt/vol) bovine serum albumin in Tris-buffered saline-Tween. West-pico chemiluminescence (Thermo Fisher) was used to visualize the results according to the manufacturer's instructions. The primary antibodies used were ab5408 (Pol II CTD), ab5095 (serine-2-phosphorylated [phospho-S2] elongating form of Pol II), and ab86601 (Nup188) and are available from Abcam. The appropriate horseradish peroxidase-conjugated secondary antibodies were sourced from Jackson ImmunoResearch.
RESULTS
MagohB expression requires KMT2B. Mll2 Ϫ/Ϫ ES cells were employed to investigate the mechanism of MagohB transcriptional regulation. These cells harbor a gene-trapping cassette in intron 1 of both alleles of Mll2 (Fig. 1A) . The nascent Mll2 transcript is spliced to the cassette, thus preventing expression of wild-type Mll2. We measured MagohB steady-state mRNA levels by reverse transcription-QPCR in the wild-type ES cell line E14 and Mll2 Ϫ/Ϫ ES cells. As reported previously (15) , MagohB expression was abolished in Mll2 Ϫ/Ϫ ES cells ( Fig. 1B ), suggesting that KMT2B is absolutely required for MagohB expression.
In order to dissect the molecular mechanism by which KMT2B activates or maintains transcription from the MagohB promoter, we first had to identify potential cis regulatory elements on the Magoh2B locus. Three conserved intronic regions which could be regulating MagohB expression were identified (through the UCSC genome browser's mammalian conservation plots) and were termed conserved sequence 1 (CS1), CS2, and CS3 (Fig. 1C ). We then employed DNase I-hypersensitive site (DHS) mapping to examine the entire MagohB gene and the immediate 5= flanking region. Hybridization with probes on either side of the restriction fragment revealed the presence of two DHSs, termed HSp and HS1 ( Fig. 1D ; results from hybridization with only one probe are shown). HSp forms over the MagohB CpG island promoter and is present only in E14 wild-type cells. Loss of HSp in the Mll2 Ϫ/Ϫ cells suggests that KMT2B is involved in maintenance of the open chromatin conformation of the MagohB promoter. HS1 forms over a simple repeat element ( Fig. 1D and data not shown), possibly because the DNA sequence of the repeat element is unfavorable for nucleosome assembly. In summary, from our data, it is highly likely that the main element driving expression of MagohB is its CpG island promoter.
MagohB is transcriptionally silenced 4 days after de novo Mll2 deletion. To establish the order of events that lead to MagohB silencing after KMT2B depletion, we employed ligand-dependent conditional mutagenesis (21) . The Mll2 F/ϩ and Mll2 F/F ES cells ubiquitously express Cre-ERT2 from the Rosa26 locus and have one or two conditional Mll2 alleles, respectively (described in more detail in references 5 and 15). Cre-ERT2 activation by 4-hy- droxytamoxifen (OHT) results in deletion of Mll2 exon 2, causing a frameshift and introducing a stop codon within exon 3 ( Fig. 2A) . We measured the efficiency and kinetics of Cre-mediated recombination by Southern blotting (Fig. 2B ) and found that recombination was complete 24 h after OHT induction. These results confirm previous studies using the same ES cell system (15) , showing similar recombination kinetics. The study described above had also demonstrated an approximately 50% reduction of KMT2B protein 12 h after Cre activation. Importantly, no outgrowth of nonrecombined cells was observed at up to 8 days postinduction, as detected by the absence of the Mll2 F allele in either cell line.
We measured MagohB steady-state mRNA levels over a 4-day period after OHT induction (Fig. 2C ). Although Mll2 deletion was complete within 1 day after addition of OHT, the first transcriptional effects on MagohB were observed at 2 days postinduction. This discrepancy can be attributed to both the stability of the MagohB mRNA and the half-life of KMT2B. Subsequently, a nearly complete depletion of MagohB mRNA was observed 4 days after OHT induction. No significant downregulation of MagohB was observed in Mll2 F/ϩ cells, indicating that one allele of Mll2 is sufficient to maintain MagohB expression.
Chromatin structure of the MagohB promoter is perturbed after KMT2B depletion. To gain insight into the mechanistic details of the different steps of MagohB silencing, we performed DNase I footprinting experiments over a time course of 8 days (Fig. 3A) . We observed a characteristic protection from DNase I digestion around the transcription start site (TSS) flanked by hypersensitive regions, suggesting the presence of a protein assem-bly, most likely the RNA polymerase II preinitiation complex. This pattern was maintained in the Mll2 F/ϩ cells throughout this time course, consistent with the aforementioned maintenance of MagohB mRNA levels in those cells. In contrast, the DNase I digestion pattern observed in Mll2 F/F cells over the MagohB TSS was altered 4 days after OHT induction, coinciding with the observed MagohB mRNA depletion. The digestion pattern observed 8 days after OHT induction very closely resembles the pattern observed in Mll2 Ϫ/Ϫ cells. This experiment demonstrates that the maintenance of DNase I-hypersensitive chromatin over the TSS requires the presence of KMT2B.
To correlate the reduction in nuclease accessibility with changes in histone modification patterns, we employed ChIP-QPCR studies. These assays revealed that loss of KMT2B and downregulation of gene expression are associated with loss of the active H3K4me 3 and H3K9ac marks ( Fig. 3B and C) , which was first observed 2 days after OHT induction in Mll2 F/F cells. The levels of both histone marks decreased to near background levels at 4 days postinduction, concomitantly with MagohB mRNA depletion. RNA polymerase II levels closely correlated with the levels of these two histone marks (Fig. 3D) . Loss of only one Mll2 allele (Mll2 F/ϩ cells) had no effect on the chromatin environment of the MagohB promoter. These results support the view that KMT2B and/or the H3K4me 3 mark is required for RNA polymerase II association with the MagohB promoter.
Chromatin architecture at MagohB promoter. DHSs and active promoters have previously been reported to be devoid of nucleosomes (22) (23) (24) (25) (26) . MNase preferentially cuts in nucleosomal linker regions in chromatin (27, 28) , which can be visualized as strong double-strand cuts in high-resolution mapping assays (19) . In addition, large nonhistone DNA-protein complexes can also be indicated by flanking MNase cuts (29) . We therefore employed MNase footprinting to examine the chromatin architecture of the MagohB promoter after deletion of Mll2. Identical MNase digestion patterns were observed in untreated Mll2 F/F and Mll2 F/ϩ cells with strong MNase cuts flanking the TSS and the active RNA polymerase II complex. This digestion pattern, especially the strong flanking sites, remained unchanged in Mll2 F/ϩ cells up to 8 days after OHT induction. In Mll2 F/F cells, however, it was altered 2 days after OHT induction (Fig. 4A) . Changes in MNase accessibility were also observed further downstream (data not shown). These findings confirmed the DNase I data demonstrating that upon loss of KMT2B, nuclease accessibility on the MagohB promoter and surrounding region was altered. To clarify whether these changes were due to nucleosome repositioning or eviction of the basal transcription machinery and/or other protein factors, we performed ChIP experiments using an antibody raised against histone H3 (Fig. 4B and C) . These experiments demonstrated that nucleosomes on the MagohB CpG island promoter were only loosely positioned, if at all, consistent with previously reported findings with CpG island promoters (30) . Most importantly, we did not detect major alterations in the nucleosome occupancy pattern at the MagohB promoter up to 8 days after OHT treatment in Mll2 F/ϩ (Fig. 4B) or Mll2 F/F (Fig. 4C ) ES cells.
DNA methylation occurs soon after transcriptional silencing. To directly investigate whether DNA methylation is a silencing initiating or maintaining event, we measured DNA methylation levels on the MagohB CpG island promoter region by bisulfite conversion and pyrosequencing over an 8-day time course. A total of 19 CpG sites distributed between bp Ϫ48 and ϩ69 from the transcription start site were examined in this assay. The results showed no significant difference in DNA methylation in Mll2 F/ϩ cells over the duration of this time course (Fig. 5A) . In contrast, increased DNA methylation at the MagohB promoter was evident in Mll2 F/F cells 4 days after OHT induction (Fig. 5B ). At this time point, the H3K4me 3 and H3K9ac histone marks along with RNA polymerase II had already been removed and transcription had ceased. We therefore conclude that DNA methylation cannot be responsible for initiating MagohB silencing in those cells. As no clear bias toward methylation (or protection from methylation) of specific CpG dinucleotides was observed, the three-dimensional graphs presented in Fig. 4A and B were summarized in a simpler box plot format (Fig. 5C ). This representation revealed a significant (at 95% confidence) overall increase in CpG methylation on the MagohB promoter in Mll2 F/F cells 4 days after OHT treatment. At the 8-day time point, CpG methylation on the MagohB promoter in Mll2 F/F cells equalled the levels measured in Mll2 Ϫ/Ϫ cells. As this method cannot distinguish between cytosine methylation and hydroxymethylation, we performed MeDIP and HmeDIP assays coupled with QPCR. We measured an increase in methylcytosine levels on the MagohB promoter exclusively in Mll2 F/F cells at 4 and 8 days after OHT treatment (Fig.  5D ), but hydroxymethylcytosine levels in both Mll2 F/ϩ and Mll2 F/F ES cells were low (Fig. 5E) . Importantly, the levels of this modification did not change after KMT2B depletion, verifying that what we detected by bisulfite conversion and pyrosequencing is indeed DNA methylation.
Transcription and RNA polymerase II are dispensable for the maintenance of the H3K4me 3 mark and for protection from DNA methylation. A recent study reports that the Drosophila homologue of KMT2B-Trx-is found to rapidly reassociate with nascent DNA after the passage of the replication fork, while H3K4-methylated histones are detected only much later (31) . Additionally, a previous report has shown that KMT2A remains bound on highly condensed mitotic chromosomes and marks genes that will be rapidly and highly induced upon entry of the cell into G 1 phase (32) . During cell division, transcription ceases and RNA polymerase II is evicted from DNA. KTM2 proteins in higher eukaryotes therefore appear to be able to bind independently of RNA polymerase II association. To gain insight into the role of KMT2B in the absence of transcription and/or RNA polymerase II, Mll2 F/F cells were treated with DRB or ␣-amanitin. DRB blocks transcriptional elongation by inhibiting p-TEFb enzymatic activity (33, 34) . ␣-Amanitin binds the active site of RNA polymerase II, and this complex is subsequently targeted for degradation (35) . Western blotting using whole-cell extracts demonstrated that the serine-2-phosphorylated elongating form of RNA polymerase II was depleted after 16 h of DRB treatment, while a 24-or 48-h ␣-amanitin treatment greatly reduced total RNA polymerase II levels (Fig. 6A ). As expected, MagohB primary transcripts ( Fig.  6B ) and steady-state mRNA (data not shown) were barely detectable following treatment with either of the two drugs. Gapdh expression levels were found to be just above detection limits (data not shown), demonstrating that this effect was not confined to MagohB. Importantly, 18S rRNA could be readily detected, as RNA polymerase I is reported to be unaffected by either of these drugs (data not shown).
We next examined the chromatin state at the MagohB pro- moter by ChIP-QPCR. We did not observe any difference in RNA polymerase II occupancy or H3K4me 3 levels in DRB-treated cells (Fig. 6C ). We measured an approximately 50% reduction in RNA polymerase II occupancy over the MagohB promoter in cells treated with ␣-amanitin, accompanied by an approximately 2-fold increase in H3K4me 3 levels. The increase in H3K4me 3 could be explained by the loss of H3K4-specific demethylases as a result of RNA polymerase II inhibition. These findings support the notion that H3K4me 3 deposition and maintenance on the MagohB promoter do not require RNA polymerase II recruitment and transcription.
To test whether the reduction in elongation or RNA polymerase II occupancy increased DNA methylation at the MagohB CpG island promoter, we examined DNA methylation levels after DRB or ␣-amanitin treatment by HpaII digestion and QPCR. We did not observe any increase in methylation of this particular CpG dinucleotide following either treatment. This result suggests that in the presence of KMT2B, protection from DNA methylation does not depend on productive transcriptional elongation and is not affected by a severe depletion of RNA polymerase II binding. The presence of KMT2B and/or the H3K4me 3 mark is sufficient to protect the MagohB promoter from the action of DNA methyltransferases.
Reactivation of endogenous Mll2 alleles is sufficient to revert MagohB to the active state. In order to examine whether DNA methylation permanently locks the MagohB promoter in the inactive state, we reactivated the endogenous Mll2 alleles in Mll2 Ϫ/Ϫ cells by transient expression of the FlpO recombinase. Expression of FlpO results in removal of the stop cassette and expression of wild-type KMT2B from the endogenous locus ( Fig. 7A ). Mll2 Ϫ/Ϫ cells were transfected with a pCAGGS-FlpO-puro plasmid and enriched by culturing in 1 g/ml puromycin-containing medium for 24 h. Successful deletion of the stop cassette and reactivation of Mll2 were verified by genotyping PCR (data not shown) and Mll2 steady-state mRNA expression measurement (Fig. 7B) . Upon reintroduction of KMT2B (14 days posttransfection), MagohB mRNA could be readily detected ( Fig. 7B ), suggesting that KMT2B action can overcome the repressive barrier posed by DNA methylation. MagohB reactivation was accompanied by the reestablishment of the H3K4me 3 mark on the MagohB promoter ( Fig.  7C) , as shown by ChIP-QPCR assays performed at the same time point. Both cytosine methylation ( Fig. 7D ) and 5= hydroxymethylation ( Fig. 7E) were detected and progressively decreased on the MagohB promoter. Our results suggest that reactivation of the endogenous Mll2 alleles and physiological levels of KMT2B expression are sufficient to reestablish the normal H3K4me 3 pattern and to induce DNA demethylation, most likely via a 5= hydroxymethylcytosine intermediate. 
DISCUSSION
KMT2B is required to establish and maintain an active chromatin environment and recruit RNA polymerase II to the MagohB promoter. The inducible Mll2-knockout system allowed us to dissect the order of events leading to MagohB silencing and demonstrate that it occurs in a sequential fashion. After KMT2B depletion, the levels of the H3K4me 3 mark decrease (herein and reference 15) with a concomitant decrease in both H3K9 acetylation and RNA polymerase II association with the MagohB promoter, resulting in transcriptional silencing. Additionally, the MagohB promoter lacks DNase I hypersensitivity in the absence of KMT2B, as shown by our DHS mapping experiments in Mll2 Ϫ/Ϫ cells.
In summary, from our data it is likely that KMT2B forms a platform that coordinates the assembly of the basal transcription machinery via multiple interactions. The transactivation domain of KMT2A has been shown to interact directly with CBP/p300containing histone acetyltransferase (HAT) complexes (36) . HAT complexes are known to act as large multiprotein scaffolds that can mediate interactions between transcription factors and the basal transcription machinery (37) . KMT2B may be involved in stabilizing the recruitment of CBP/p300-containing complexes, which can in turn recruit the transcriptional apparatus. The preinitiation complex may be further stabilized by TF II D binding to H3K4-trimethylated nucleosomes (38, 39) flanking the MagohB promoter. This model predicts that loss of KMT2B would result in loss of histone acetylation and RNA polymerase II, which is precisely what we observed.
KMT2B action is not dependent on transcription or the presence of RNA polymerase II. Our experiments using DRB and ␣-amanitin demonstrate that in the presence of KMT2B, RNA polymerase II recruitment and transcriptional elongation are largely dispensable for the maintenance of H3K4 trimethylation. This result is consistent with the hypothesis that MLL proteins (KMT2A to KMT2D) operate differently from yeast Set1 and have a causal role in transcriptional activation. Previous studies have hinted to such a mechanism, as depletion of KMT2A resulted in changes in RNA polymerase II distribution on KMT2A target genes (12, 13) . Moreover, it has been demonstrated that CpG islands recruit H3K4 methyltransferases regardless of their transcriptional activity (40) . Our experiments provide direct evidence that neither active transcription nor the presence of the RNA polymerase II preinitiation complex is required to maintain the H3K4me 3 mark over a CpG island promoter, further suggesting that MLL (KMT2A to KMT2D) proteins act upstream of RNA polymerase II recruitment.
KMT2B confers protection from DNA methylation. How CpG islands are protected from DNA methylation has been a long-standing subject of research. Our data clearly demonstrate that loss of the H3K4me 3 mark results in the rapid onset of DNA methylation at multiple CpG dinucleotides over the MagohB CpG island promoter. Moreover, transcriptional elongation and RNA polymerase II did not appear to play a role in MagohB methylation protection, as illustrated by our experiments using DRB and ␣-amanitin. In turn, we show that reexpression of KMT2B is sufficient to induce demethylation of the methylated MagohB promoter, the reestablishment of its normal H3K4me 3 pattern, and the activation of transcription ( Fig. 7D and E ). This indicates that once all activators are present, the RNA polymerase II complex efficiently reassociates and overrides the silent state. It has previously been demonstrated that H3K4me 3 may confer protection from DNA methylation (41) , as the DNA methyltransferase common subunit-DNMT3L-can interact only with unmethylated H3K4. As such, KMT2 catalytic activity would preclude DNA methyltransferase recruitment, thus conferring protection from DNA methylation to KMT2 target promoters. In addition, physically retaining KMT2B on chromatin during replication may further protect from DNA methyltransferase action. The detailed dissection of these processes is a current subject of further experimentation outside the scope of this study.
KMT2B in CpG island promoter regulation. Based on our results, we propose a model for the role of KMT2B in MagohB transcriptional regulation (Fig. 8 ). After KMT2B depletion, the H3K4me 3 mark is either actively removed or diluted over consecutive cell divisions, resulting in loss of the H3K9ac mark. RNA polymerase II can no longer associate with the MagohB promoter, as its recruitment may be facilitated or stabilized by direct interactions of TF II D with the H3K4me 3 mark (38, 39) and interactions with CBP/p300-containing HAT complexes (36, 37) . As the preinitiation complex is removed, transcription ceases. After the H3K4me 3 mark and/or KMT2B has been removed from the MagohB promoter, DNA methyltransferases are able to target and de novo methylate the MagohB CpG island. We believe that such a scenario is avoided at most genes by the high level of redundancy within the KMT2 family of histone methyltransferases. However, the specific developmental defects of individual KMT2 family member knockouts indicate that windows in development exist where the dynamic activation of genes becomes dependent on a specific family member. Currently, the transcription factors recruiting KMT2A/B-containing complexes are not known. The MagohB promoter binds Sp1 and Sp3 in vitro, but no binding could be detected in ChIP experiments, and deletion of either factor individually did not influence MagohB mRNA levels (data not shown). Whatever recruits KMT2A/B complexes, our model helps to explain why once a transcriptional network has been destabilized in the context of tumorigenesis, CpG island promoters become vulnerable to gene silencing.
